From FASTQ to Clinical Report.

We provide a complete end-to-end solution for clinical labs and hospitals to analyze Next-Generation Sequencing data.


In business for 20 years and cited in 1,200+ publications, we are proud to support over 10,000 users in more than 350 institutions worldwide.


Our entire clinical pipeline consists of software products that are deeply integrated with each other. In addition, we provide automation capabilities that are crucial in high-throughput testing environments.


Save money with an annual subscription! No hidden fees. No per-sample charges. Licenses include unlimited training and support to ensure success.

Featured Products

SNP & Variation Suite

SNP & Variation Suite

  • GWAS & SNP Analysis
  • Large-N DNA-Seq Analysis
  • Genomic Prediction
  • Copy Number Analysis
  • RNA-Seq Analysis

Learn More



  • Fully Integrated with VarSeq Workflows
  • Scalable Technology
  • Organize Samples into Projects
  • Centralized Clinical Report Hosting
  • Create Variant Assessment Catalogs

Learn More 

Don't Miss the Good Stuff!

Golden Helix Newsletter Sign-up

Join our mailing list to receive the latest Golden Helix product news, big discounts on great software, special announcements and more.

Support for Various Industries

Customer Testimonials

Rutgers Cancer Institute of New Jersey

“Being an informatics person, my job is to set the system up. Now that it’s up and running the molecular pathologist can run the samples. They do not need an informatics person to run every sample.”

Dr. Jeffrey Rosenfeld, Bioinformatics Scientist

Read Rosenfeld's Case Study

University of Iowa

“VarSeq had everything we were looking for with regards to annotation, filtering sources and an actual visual browser within the software itself. But what really set it apart in retrospect is how intuitive it is.”

Dr. Benjamin Darbro, Director of Shivanand R. Patil Cytogenetics and Molecular Laboratory

Read Darbro's Case Study

Center for Rare Jewish Genetic Disorders

“The VarSeq software provides beautiful filtering and annotation for our samples. However, what really impressed us was the ability of VSWarehouse to help us to generate a population catalogue specific to the Ashkenazi Jewish community.”

Chaim Jalas, Director of Genetic Resources & Services

Read Jalas' Case Study

University of Iowa

“It [SVS] opened so many doors for my research. It allowed me to explore new ideas. It allowed me to do stuff I never thought was even possible to do in that amount of time, so I could test so many hypotheses. All that I had to do is click a button.”

Dr. Hela Azaiez, Associate Research Scientist, Molecular Otolaryngology and Renal Research Laboratories

Read Azaiez's Case Study

University of Arizona

"SVS goes beyond simple genotype associations with Identity By Descent (IBD) calculations, principal component analysis, and the ability to visualize results, all in one application. So when people say 'It costs money,' I respond that it's better to have one program that can do everything than to have to look for updates on multiple applications all the time."

Dr. Rick Kittles, Director, Center for Population Genetics

Read Kittle's Case Study

Cornell University

"That's one of the huge benefits of SVS - it's user-friendly and you can basically visualize your results in the same program. So you don't have to spend nearly as much time manipulating data and results to get it in the right input and output formats."

Dr. Heather Huson, Professor of Dairy Cattle Genetics, Odyssey DNA Lab

Read Huson's Case Study

Recent Webcast

Introducing VS-Clinical - Streamlining ACMG Variant Interpretation Guidelines

Presented by: Gabe Rudy | VP of Product & Engineering, Golden Helix

We have seen the widespread adoption of VarSeq in the clinic. It is chosen for its versatility and flexibility as well as the extensive catalog of annotations provided by Golden Helix. In a genetic testing scenario, VarSeq provides the annotated and filtered list of high-quality variants to that are ready for the user to classify and interpret.

In this webcast, we introduce a new product VS-Clinical that enables the interpretation of variants following the ACMG Guidelines. By incorporating new algorithms and annotation sources, detailed variant scoring and classification can occur right within VarSeq and without the need for additional external tools or resources.

Join us to see these upcoming capabilities:

  • Streamline the ACMG scoring guidelines with supportive recommendation and incorporated historical precedence
  • See the new algorithms behind the automated recommendation algorithm, and how they provide various levels of evidence
  • Drill down to an unprecedented level of supporting evidence for mutation hot spots, splice site predictions, and related clinical assertions
  • Build your own lab practices around new capabilities of blinded interpretations, collaborative interpretation review and detailed audit logs for CLIA compliance
  • Finalize your interpretation for a sample and compose the clinical report with the classified variants and their interpretation

In combination, this can be a game changer for any clinical lab looking to improve their efficiency and reproducibility of the most complex step in the genetic testing workflow.